Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patiromer-facilitated escalation of mineralocorticoid antagonists in heart failure with hyperkalaemia
2018-003662-14Phase 4Unknown
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Mar 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of patiromer in heart failure (HF) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Status: unknown.
02
Drugs
patiromer
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2018-003662-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003662-14.